Accredited Investors Employee Shareholders Institutions Private Companies Who We Serve Trading and InvestingData SolutionsPrivate Asset Custody Institutional TradingForge ProTrade private companies with Forge’s institutional brokerage toolBrowse CompaniesIndividual InvestingForge MarketsFind new private company investment opportunitiesForge DataAnalyze private markets via Forge’s intuitive web applicationForge Private Market IndexMonitor a benchmark for actively traded private companies Forge Accuidity Private Market IndexInvest in an institutionally-managed diversified basket of private companies (QPs only)Self-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRASolutions All InsightsPrivate Market ReportsMarket InsightsBuying and Selling Pre-IPO All ReportsPrivate Market Updates Forge Investment OutlookStartup News and TrendsPrivate Market Data and AnalyticsTech IPO Calendar for 2024Private Market ExplainedBuying Pre-IPO SharesSelling Pre-IPO Shares Glossary Videos FAQsInsights About Us Leadership Investor Relations People & Culture Careers About

Bolt Biotherapeutics Stock

Q: How to sell Bolt Biotherapeutics stock?

If you hold private company shares of Bolt Biotherapeutics - whether as an employee or an early investor - Forge can help you sell them. 1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have. 2. Indicate your interest to sell your Bolt Biotherapeutics stock on our platform. 3. Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

boltbio.comHealthcare / BioTech & PharmaFounded: 2015Funding to Date: $64.6MM

Bolt Biotherapeutics is a biotechnology company developing Boltbody™ Immune-stimulating Antibody Conjugates (ISAC), a new class of immuno-oncology therapeutics that have eliminated tumors following systemic administration in preclinical studies and results in the development of immunological memory, which may lead to more durable clinical responses for patients.

Buy or sell Bolt Biotherapeutics stockLearn more about Bolt Biotherapeutics IPO

OverviewFinancingsValuation

Enterprise Value

Access Bolt Biotherapeutics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Bolt Biotherapeutics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Chih-Ping Liu Ph.D

Co-Founder & President

Randall Schatzman Ph.D

Chief Executive Officer & Board Member

Edgar Engleman

Co-Founder & Board Member

Grant Yonehiro

Chief Business Officer & Chief Operating Officer

Board Members

Ashish Khanna Ph.D

NFLS - Pivotal

Randall Schatzman Ph.D

Edgar Engleman

Peter Moldt

Richard Miller MD

Ken Harrison

Peter Bisgaard

Mahendra Shah

Bolt Biotherapeutics stock FAQs

Can you buy Bolt Biotherapeutics stock?

As Bolt Biotherapeutics is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like Bolt Biotherapeutics, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.

How to buy Bolt Biotherapeutics stock?

To invest in a private company like Bolt Biotherapeutics through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

Create a free account to access Forge’s marketplace.
Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell Bolt Biotherapeutics stock?

Yes, you may be able to sell your Bolt Biotherapeutics stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.

How to sell Bolt Biotherapeutics stock?

If you hold private company shares of - whether as an employee or an early investor - Forge can help you sell them.

Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
Indicate your interest to sell your Bolt Biotherapeutics stock on our platform.
Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.

Is Bolt Biotherapeutics a public company?

No, Bolt Biotherapeutics is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is Bolt Biotherapeutics’ stock price?

Bolt Biotherapeutics is a privately held company and therefore does not have a public stock price. However, you may access Bolt Biotherapeutics’ private market stock price with Forge Data.

What is Bolt Biotherapeutics’ stock ticker symbol?

Bolt Biotherapeutics does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

PR Newswire 01/09/2020

Bolt Biotherapeutics Expands Scientific Advisory Board with Appointment of Dr. Priti Hegde

/PRNewswire/ -- Bolt Biotherapeutics, Inc., a private biotechnology company focused on using its Immune-Stimulating Antibody Conjugate (ISAC) platform...

FierceBiotech 11/11/2019

Bolt Bio preps clinical trials of immune-stimulating cancer drug in stubborn solid tumors

Bolt Biotherapeutics, founded by Stanford immuno-oncology veteran Edgar Engleman, is developing new class of cancer drugs called immune stimulating antibody conjugates. Backed by fresh data from animal trials of its lead drug, a tumor-targeting antibody connected to an immune stimulator, the company is preparing a phase 1 trial.

Xconomy 02/05/2019

Xconomy: Bolt Bio Bags $54M for Drugs that Turn the Heat Up on “Cold” Tumors

In cancer lingo, “cold” tumors are cancers that the immune system doesn’t recognize or respond to, even when immune-stimulating drugs are given. Bolt

Browse More Insights

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.